Headlines about WebMD Health Corp. (NASDAQ:WBMD) have been trending positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. WebMD Health Corp. earned a news sentiment score of 0.39 on Accern’s scale. Accern also gave news articles about the health services provider an impact score of 46.3244395677976 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media stories that may have effected Accern’s rankings:
- Pre-Market Technical Recap on Healthcare Information Services … - Markets Insider (markets.businessinsider.com)
- Two Stocks You May Need To Reconsider: WebMD Health Corp. (WBMD), Double Eagle Acquisition Corp. (EAGL) - AllStockNews (allstocknews.com)
- READ NOW: Monteverde & Associates PC is Investigating the Tender Offer of WebMD Health Corp Set to Expire on September 7, 2017 - WBMD (finance.yahoo.com)
- WebMD Health Corp (NASDAQ:WBMD) Traded 6.1% Above Its 50 Day Average (highlightpress.com)
- Pre-Market Technical Recap on Healthcare Information Services Stocks — WebMD Health, Medical Transcription Billing, Evolent Health, and Cerner (prnewswire.com)
WebMD Health Corp. (NASDAQ WBMD) opened at 66.32 on Thursday. WebMD Health Corp. has a 52 week low of $48.10 and a 52 week high of $66.45. The company has a market cap of $2.42 billion, a P/E ratio of 33.96 and a beta of 0.78. The company’s 50-day moving average is $62.76 and its 200-day moving average is $56.42.
A number of analysts have weighed in on WBMD shares. Zacks Investment Research upgraded shares of WebMD Health Corp. from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research report on Thursday, August 17th. KeyCorp downgraded shares of WebMD Health Corp. to an “overweight” rating in a research note on Wednesday, August 2nd. BidaskClub raised shares of WebMD Health Corp. from a “strong sell” rating to a “sell” rating in a research note on Friday, June 23rd. Citigroup Inc. downgraded shares of WebMD Health Corp. from a “buy” rating to a “neutral” rating and raised their price target for the company from $62.00 to $66.50 in a research note on Wednesday, July 26th. Finally, Raymond James Financial, Inc. downgraded shares of WebMD Health Corp. from an “outperform” rating to a “mkt perform” rating in a research note on Wednesday, July 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $65.25.
ILLEGAL ACTIVITY WARNING: This piece was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/08/24/positive-press-coverage-somewhat-unlikely-to-affect-webmd-health-corp-wbmd-stock-price.html.
WebMD Health Corp. Company Profile
WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals through its Websites, mobile applications and health-focused publications. Advertisers and sponsors use The WebMD Health Network to reach and engage healthcare professionals and consumers who are interested in healthy living, wellness, diseases and conditions, and other health-related topics.
Receive News & Ratings for WebMD Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp. and related companies with MarketBeat.com's FREE daily email newsletter.
